The programme for Australia’s inaugural boutique medtech investment roundtable, AusMedtechInvest 2024, is packed and features speakers from leading investment firms ARCHIMED, Artesian, Brandon Capital, Main Sequence, OneVentures, and Tenmile, as well as investment pitch presentations from medtech executives.
Events
New Stories
-
AusMedtechInvest keynote and panel speakers announced
April 30, 2024 - - AusBiotech -
Mesoblast announces the appointment of new board chair
April 30, 2024 - - Latest News -
Opyl expands coverage TrialKey of clinical trial prediction and design optimisation
April 30, 2024 - - Latest News -
FivepHusion announces ethics approval of Phase 1b trial of deflexifol as first-line treatment
April 30, 2024 - - Latest News -
Alterity Therapeutics presents new data demonstrating potential of ATH434
April 30, 2024 - - Latest News -
AusBiotech announces incoming CEO
April 23, 2024 - - AusBiotech -
Osteopore launches first first-in-human clinical trials begin in Singapore
April 23, 2024 - - Latest News